Distribution of intestinal metaplasia as a predictor of gastric cancer development

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 8, 2015, Pages 1260-1264

  Shichijo, Satoki ^a   Hirata, Yoshihiro ^a   Sakitani, Kosuke ^a   Yamamoto, Shinzo ^a   Serizawa, Takako ^a   Niikura, Ryota ^a   Watabe, Hirotsugu ^a   Yoshida, Shuntaro ^a   Yamada, Atsuo ^a   Yamaji, Yutaka ^a   Ushiku, Tetsuo ^b   Fukayama, Masashi ^b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; ARTICLE; BACTERIAL CLEARANCE; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; GASTRITIS; HAZARD RATIO; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CODING; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH ANTRUM; STOMACH CANCER; STOMACH CARCINOGENESIS; UNIVERSITY HOSPITAL; AGED; COMPLICATION; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER PYLORI; INCIDENCE; INTESTINE; METAPLASIA; MICROBIOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; STOMACH NEOPLASMS;

AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84937391470     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12946     Document Type: Article

References (20)

1. Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 1995; 19 (Suppl. 1): S37-43.
2. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659-672.
3. Uemura N, Okamoto S, Yamamoto S etal. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-789.
4. Shiotani A, Iishi H, Uedo N etal. Histologic and serum risk markers for noncardia early gastric cancer. Int. J. Cancer 2005; 115: 463-469.
5. Hsu PI, Lai KH, Hsu PN etal. Helicobacter pylori infection and the risk of gastric malignancy. Am. J. Gastroenterol. 2007; 102: 725-730.
6. de Vries AC, van Grieken NC, Looman CW etal. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952.
7. Cassaro M, Rugge M, Gutierrez O etal. Topographic patterns of intestinal metaplasia and gastric cancer. Am. J. Gastroenterol. 2000; 95: 1431-1438.
8. Sakitani K, Hirata Y, Watabe H etal. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J. Gastroenterol. Hepatol. 2011; 26: 1570-1575.
9. Ogura K, Hirata Y, Yanai A etal. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J. Clin. Gastroenterol. 2008; 42: 279-283.
10. Capelle LG, de Vries AC, Haringsma J etal. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest. Endosc. 2010; 71: 1150-1158.
11. den Hoed CM, Holster IL, Capelle LG etal. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy 2013; 45: 249-256.
12. Tava F, Luinetti O, Ghigna MR etal. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Hum. Pathol. 2006; 37: 1489-1497.
13. de Vries AC, Haringsma J, de Vries RA etal. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest. Endosc. 2009; 70: 18-25.
14. Yanaoka K, Oka M, Ohata H etal. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int. J. Cancer 2009; 125: 2697-2703.
15. Wong BC, Lam SK, Wong WM etal. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194.
16. Wu CY, Kuo KN, Wu MS etal. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009; 137: 1641-1648, e1-2.
17. Fukase K, Kato M, Kikuchi S etal. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
18. de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am. J. Gastroenterol. 2009; 104: 1342-1345.
19. Yoshida T, Kato J, Inoue I etal. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int. J. Cancer 2014; 134: 1445-1457.
20. Solcia E, Fiocca R, Luinetti O etal. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am. J. Surg. Pathol. 1996; 20 (Suppl. 1): S8-22.